CRISPR activation screens identify oncogenic lncRNAs that are susceptible to CDK4/6 inhibitor treatment

Journal:
Nature Communications
Published:
Affiliations:
5
Authors:
12
Institutions Authors Share
University of Pittsburgh (Pitt), United States of America (USA)
11.750000
11.750000
0.98
UPMC Hillman Cancer Center (UPCI), United States of America (USA)
0.250000
0.02